I am a globally trained physician–scientist, health policy leader, social entrepreneur, and Executive Director building neurotechnology and brain health innovation ecosystems.

I currently lead the NeuroTech Innovation Hub at Charité's ARC Innovation Center, building a Berlin-based multisectoral innovation ecosystem that connects clinical neuroscience, neurotechnology, academia, industry, funders, and public-sector partners to translate innovation into clinically meaningful, ethically grounded, and system-ready impact.

My work focuses on neurotechnology, AI/digital health, and health policy with an emphasis on responsible innovation, governance, and health system integration. I work across public–private interfaces to bridge science, regulation, and real-world deployment.

Previously, I served as Technical Consultant at the World Health Organization (Brain Health Unit), where I led the development of WHO’s first Global Status Report on Neurology. Prior to that, I headed Policy and Research at the International Bureau for Epilepsy, directing global implementation initiatives, and co-founded the non-profit organization R3SOLUTE, serving as its Chief Medical Officer. I trained as a physician–scientist at Charité – Universitätsmedizin Berlin and am an Affiliate Researcher at Mass General Brigham Cancer Institute, Harvard Medical School.

My work has been published in world-leading journals including The Lancet, JAMA, Neurology, Neuro-Oncology, AI & Ethics, and Brookings Institution Press. I serve as Commissioner for the Lancet Commission on Neurorehabilitation and Senior Editor of the forthcoming Springer Nature Textbook Neurotoxicity in Cancer Therapy.

An alumnus of the German National Academic Foundation, I hold a Ph.D. (summa cum laude) and M.D. (with distinction) from Charité, as well as a B.Sc. in Neuroscience (First Class Honours) from King’s College London.

Focus: neurotechnology & brain health ecosystems, science-for-policy, public–private partnerships, global-to-local orchestration, and responsible innovation.